Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J0695 |
Short Description | Inj ceftolozane tazobactam |
Long Description | Injection, ceftolozane 50 mg and tazobactam 25 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2016-01-01 |
Date Added | 2016-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
67919003001 | J0695 | Inj ceftolozane tazobactam | ZERBAXA | CUBIST PHARMACEUTICALS | 75mg (50mg cft/25mg taz) | 1 | 10 | 20 | 200 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 75mg (50mg cft/25mg taz) |
HCPCS/CPT Billing Units | 0.013333333333333 |
Total doses ordered | |
Billing Units | 0.013333333333333 |
Drug Details
-
The combination of ceftolozane and tazobactam is used to treat certain infections including urinary tract infections and infections of the abdomen (stomach area). It is also used to treat certain types of pneumonia that developed in people who are on ventilators or who were in a hospital. Ceftolozane is in a class of antibiotics called cephalosporins. It works by killing bacteria. Tazobactam is in a class called beta-lactamase inhibitor. It works by preventing bacteria from destroying ceftolozane. Antibiotics will not work for colds, flu, or other viral infections.